Article Details
Retrieved on: 2018-02-17 21:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Finally, <b>Renaissance Technologies</b> LLC grew its position in Cascadian Therapeutics by 28.1% during the fourth quarter. <b>Renaissance Technologies</b> LLC now owns 81,688 shares of the biopharmaceutical company's stock valued at $302,000 after acquiring an additional 17,900 shares during the period.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here